menu
    • menu

    Company profile for Aro Biotherapeutics

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Aro Biotherapeutics is focused on the development of a new protein drug platform called Centyrins, designed to achieve better efficacy and safety profiles for patients with cancer and other serious diseases. Centyrins are small, non-antibody protein scaffolds that can be expressed as multi-specifics with novel therapeutic mechanisms of action. Centyrins are also ideal for the targeted delivery of complex drug payloads, includi...
    Aro Biotherapeutics is focused on the development of a new protein drug platform called Centyrins, designed to achieve better efficacy and safety profiles for patients with cancer and other serious diseases. Centyrins are small, non-antibody protein scaffolds that can be expressed as multi-specifics with novel therapeutic mechanisms of action. Centyrins are also ideal for the targeted delivery of complex drug payloads, including nucleic acids.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Aro BiotherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    The Pennovation Center 3401 Grays Ferry Avenue Philadelphia, PA 19146
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.arobiotx.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Aro Bio Completes Phase 1b Trial Enrollment For Abx1100
    Aro Bio Completes Phase 1b Trial Enrollment For Abx1100

    24 Sep 2025

    // PHARMAWEB

    https://www.pharmiweb.com/press-release/2025-09-24/aro-biotherapeutics-completes-enrollment-in-phase-1b-trial-of-targeted-sirna-therapy-abx1100-in-la

    PHARMAWEB
    24 Sep 2025
    Share Share
    Aro Biotherapeutics Appoints Purnanand Sarma as CEO
    Aro Biotherapeutics Appoints Purnanand Sarma as CEO

    11 Feb 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250211732563/en

    BUSINESSWIRE
    11 Feb 2025
    Share Share
    Aro Biotherapeutics Gets IND Clearance for ABX1100 in Pompe Disease
    Aro Biotherapeutics Gets IND Clearance for ABX1100 in Pompe Disease

    05 Feb 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250205483983/en

    BUSINESSWIRE
    05 Feb 2025
    Share Share
    Aro Bio Doses First Patient In ABX1100 Trial For Pompe Disease
    Aro Bio Doses First Patient In ABX1100 Trial For Pompe Disease

    23 Jan 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250123591368/en

    BUSINESSWIRE
    23 Jan 2025
    Share Share
    Aro Biotherapeutics Names Glenn Crater As Chief Medical Officer
    Aro Biotherapeutics Names Glenn Crater As Chief Medical Officer

    07 Jan 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250107570711/en

    BUSINESSWIRE
    07 Jan 2025
    Share Share
    Aro Biotherapeutics Opens Phase 1b Trial for ABX1100 in LOPD
    Aro Biotherapeutics Opens Phase 1b Trial for ABX1100 in LOPD

    29 Oct 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20241029266458/en

    BUSINESSWIRE
    29 Oct 2024
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search